A Randomised, Double-blind, Placebo-controlled, Multiple Oral Dose, Dose Escalation Trial, Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC 55-0414 in Patients With Type 2 Diabetes
This trial is conducted in Europe. A seven day dose escalation study in subjects with type 2 diabetes.
100 项与 NNC 55-0414 相关的临床结果
100 项与 NNC 55-0414 相关的转化医学
100 项与 NNC 55-0414 相关的专利(医药)
100 项与 NNC 55-0414 相关的药物交易